Overview
Congenital microencephaly, often associated with primordial dwarfism, encompasses a spectrum of genetic disorders characterized by severe growth retardation, distinctive craniofacial features, and neurological abnormalities including microcephaly 1235.Diagnosis
Clinical Features: Severe proportionate dwarfism, microcephaly, high forehead with receded hairline, sparse scalp hair, beaked nose, retrognathia, hypotonia, and distinctive hand and foot anomalies 125.
Genetic Testing: Identification of mutations in genes such as PCNT (Majewski osteodysplastic primordial dwarfism type II) through molecular analysis and Western blot for pericentrin protein 1.
Radiographic Findings: Characteristic skeletal dysplasia evident on X-rays, including metaphyseal flare, V-shaped femoral metaphyses, and bowing of forearms 45.
Differential Diagnosis: Distinguishing from other forms of primordial dwarfism and Seckel syndrome, noting heterogeneity and potential overlap in clinical presentations 26.Management
Supportive Care: Focus on addressing developmental delays, feeding difficulties, and musculoskeletal issues through physical therapy and occupational therapy 5.
Neurological Monitoring: Regular assessments for cerebrovascular complications and other neurological deficits, given the potential for severe cerebral vessel development issues 1.
Genetic Counseling: Essential for families to understand inheritance patterns and risks 15.Special Populations
Pediatrics: Early intervention programs crucial for developmental support and management of motor and cognitive delays 5.
Comorbidities: Increased risk of cerebrovascular malformations requiring vigilant monitoring and potential surgical intervention 1.Key Recommendations
Genetic Testing for PCNT Mutations: Consider genetic testing for PCNT mutations in patients with clinical features suggestive of MOPD II to confirm diagnosis (Evidence: Strong 1).
Comprehensive Developmental Support: Implement early and ongoing developmental support services tailored to individual needs (Evidence: Moderate 5).
Radiographic Evaluation: Perform skeletal X-rays to identify characteristic dysplasia patterns aiding in diagnosis and management planning (Evidence: Moderate 45).References
1 Piane M, Della Monica M, Piatelli G, Lulli P, Lonardo F, Chessa L et al.. Majewski osteodysplastic primordial dwarfism type II (MOPD II) syndrome previously diagnosed as Seckel syndrome: report of a novel mutation of the PCNT gene. American journal of medical genetics. Part A 2009. link
2 Buebel MS, Salinas CF, Pai GS, Macpherson RI, Greer MK, Perez-Comas A. A new Seckel-like syndrome of primordial dwarfism. American journal of medical genetics 1996. link1096-8628(19960823)64:3<447::AID-AJMG1>3.0.CO;2-M)
3 al Gazali LI, Hamada M, Lytle W. Microcephalic osteodysplastic primordial dwarfism type II. Clinical dysmorphology 1995. link
4 Hersh JH, Joyce MR, Spranger J, Goatley EC, Lachman RS, Bhatt S et al.. Microcephalic osteodysplastic dysplasia. American journal of medical genetics 1994. link
5 Verloes A, Lambrechts L, Senterre J, Lambotte C. Microcephalic osteodysplastic dwarfism (type II-like) in siblings. Clinical genetics 1987. link
6 Winter RM, Wigglesworth J, Harding BN. Osteodysplastic primordial dwarfism: report of a further patient with manifestations similar to those seen in patients with types I and III. American journal of medical genetics 1985. link